Levels of total tau in specimens of cerebrospinal fluid from patients with neurodegenerative diseases ranged 17.2–1100 pg/mL [114], and this study identified total tau in ascites within the same range of concentrations, suggesting a role in pathology. This evidence concerns the gene MAPT and neurodegenerative disease.